The Neuropeptide Y (NPY) Y2 Receptors Are Largely Dimeric in the Kidney, but Monomeric in the Forebrain

REFERENCES

• Dinger M C, Bader J E, Kobor A D, Kretzschmar A K, Beck-Sickinger A G. Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem 2003; 278: 10562–10571
   PubMed Web of Science ®Google Scholar
• Parker S L, Parker M S, Sallee F R, Balasubramaniam A. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regul Pept 2007; 144: 72–81
   Google Scholar
• Baneres J L, Parello J. Structure-based analysis of GPCR function: Evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 2003; 329: 815–829
   PubMed Web of Science ®Google Scholar
• Nobles M, Benians A, Tinker A. Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells. Proc Natl Acad Sci U SA 2005; 102: 18706–18711
   PubMed Web of Science ®Google Scholar
• Ridge K D, Palczewski K. Visual rhodopsin sees the light: Structure and mechanism of G protein signaling. J Biol Chem 2007; 282: 9297–9301
   PubMed Web of Science ®Google Scholar
• Estes A M, Wong Y Y, Parker M S, Sah R, Balasubramaniam A, Sallee F R, Parker S L, Neuropeptide Y. (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric. Regul Pept 2008, submitted
   Google Scholar
• Armstrong D, Strange P G. Dopamine D2 receptor dimer formation: Evidence from ligand binding. J Biol Chem 2001; 276: 22621–22629
   PubMedGoogle Scholar
• Ciruela F, Casado V, Mallol J, Canela E I, Lluis C, Franco R. Immunological identification of A1 adenosine receptors in brain cortex. J Neurosci Res 1995; 42: 818–828
   PubMed Web of Science ®Google Scholar
• Xi Z X, Ramamoorthy S, Baker D A, Shen H, Samuvel D J, Kalivas P W. Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine. J Pharmacol Exp Ther 2002; 303: 608–615
   PubMed Web of Science ®Google Scholar
• De Jesus M L, Salles J, Meana J J, Callado L F. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates. Neuroscience 2006; 140: 635–643
   Google Scholar
• Horowitz L F, Hirdes W, Suh B C, Hilgemann D W, Mackie K, Hille B, Phospholipase C. in living cells: activation, inhibition, Ca2+ requirement, and regulation of M current. J Gen Physiol 2005; 126: 243–262
   PubMed Web of Science ®Google Scholar
• Wong R, Fabian L, Forer A, Brill J A. Phospholipase C and myosin light chain kinase inhibition define a common step in actin regulation during cytokinesis. BMC Cell Biol 2007; 8: 15
   Google Scholar
• Doods H, Gaida W, Wieland H A, Dollinger H, Schnorrenberg G, Esser F, Engel W, Eberlein W, Rudolf K. BIIE0246: A selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol 1999; 384: R3–R5
   Google Scholar
• Parker S L, Parker M S, Crowley W R. Characterization of rabbit kidney and brain pancreatic polypeptide-binding neuropeptide Y receptors: Differences with Y1 and Y2 sites in sensitivity to amiloride derivatives affecting sodium transport. Regul Pept 1999; 82: 91–102
   Google Scholar
• Parker S L, Parker M S, Sah R, Balasubramaniam A, Sallee F R. Pertussis toxin induces parallel loss of neuropeptide Y Y(1) receptor dimers and G(i) alpha subunit function in CHO cells. Eur J Pharmacol 2008; 579: 13–25
   Google Scholar
• Munson P J, Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding proteins. Anal Biochem 1980; 107: 220–239
   PubMed Web of Science ®Google Scholar
• Parker M S, Crowley W R, Parker S L. Differences in cation sensitivity of ligand binding to Y1 and Y2 subtype of neuropeptide Y receptor of rat brain. Eur. J. Pharmacol. 1996; 318: 193–200
   Google Scholar
• Neer E J, Wolf L G, Gill D M. The stimulatory guanine-nucleotide regulatory unit of adenylate cyclase from bovine cerebral cortex. ADP-ribosylation and purification. Biochem J 1987; 241: 325–336
   PubMedGoogle Scholar
• Raymond J R, Olsen C L, Gettys T W. Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha. Biochemistry 1993; 32: 11064–11073
   PubMed Web of Science ®Google Scholar
• Brann M R, Collins R M, Spiegel A. Localization of mRNAs encoding the alpha-subunits of signal-transducing G-proteins within rat brain and among peripheral tissues. FEBS Lett 1987; 222: 191–198
   PubMedGoogle Scholar
• Stow J L, Sabolic I, Brown D. Heterogeneous localization of G protein alpha-subunits in rat kidney. Am J Physiol 1991; 261: F831–840
   Google Scholar
• Freitag C, Svendsen A B, Feldthus N, Lossl K, Sheikh S P. Coupling of the human Y2 receptor for neuropeptide Y and peptide YY to guanine nucleotide inhibitory proteins in permeabilized SMS-KAN cells. J Neurochem 1995; 64: 643–650
   PubMed Web of Science ®Google Scholar
• Sheikh S P, Sheikh M I, Schwartz T W. Y2-type receptors for peptide YY on renal proximal tubular cells in the rabbit. Am J Physiol 1989; 257: F978–984
   Google Scholar
• Price J S, Kenny A J, Huskisson N S, Brown M J. Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney. Br J Pharmacol 1991; 104: 321–326
   Google Scholar
• Berglund M M, Schober D A, Esterman M A, Gehlert D R, Neuropeptide Y. Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther 2003; 307: 1120–1126
   PubMedGoogle Scholar
• Granier S, Terrillon S, Pascal R, Demene H, Bouvier M, Guillon G, Mendre C. A cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein. J Biol Chem 2004; 279: 50904–50914
   Google Scholar
• Breen C M, Mannon P J, Benjamin B A. Peptide YY inhibits vasopressin-stimulated chloride secretion in inner medullary collecting duct cells. Am J Physiol 1998; 275: F452–457
   Google Scholar
• Breyer M D, Breyer R M. G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 2001; 63: 579–605
   PubMed Web of Science ®Google Scholar
• Gao L, Zhu C, Jackson E K. alpha 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther 2003; 305: 581–586
   Google Scholar
• Becker M, Umrani D, Lokhandwala M F, Hussain T. Increased renal angiotensin II AT1 receptor function in obese Zucker rat. Clin Exp Hypertens 2003; 25: 35–47
   PubMed Web of Science ®Google Scholar
• Grouzmann E, Meyer C, Burki E, Brunner H, Neuropeptide Y. Y2 receptor signalling mechanisms in the human glioblastoma cell line LN319. Peptides 2001; 22: 379–386
   Google Scholar
• Mochizuki N, Urasawa K, Sanchez A, Insel P A. Developmental regulation of the alpha-subunit of Gq/G11 as determined by quantitative immunoblot analysis. Biochem Biophys Res Commun 1995; 210: 246–252
   Google Scholar
• Labelle M, Boulanger Y, Fournier A, St Pierre S, Savard R. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides 1997; 18: 801–808
   PubMed Web of Science ®Google Scholar
• Zhou J, Sims C, Chang C H, Berti-Mattera L, Hopfer U, Douglas J. Proximal tubular epithelial cells possess a novel 42-kilodalton guanine nucleotide-binding regulatory protein. Proc Natl Acad Sci U SA 1990; 87: 7532–7535
   Google Scholar
• Armstrong D N, Krenz H K, Modlin I M, Ballantyne G H. Bile salt inhibition of motility in the isolated perfused rabbit terminal ileum. Gut 1993; 34: 483–488
   Google Scholar
• Lang S A, Maron M B. Effect of neuropeptide Y on hemodynamics of the rabbit lung. J Appl Physiol 1998; 84: 618–623
   Google Scholar
• McDonald J K, Han C, Noe B D, Abel P W. High levels of NPY in rabbit cerebrospinal fluid and immunohistochemical analysis of possible sources. Brain Res 1988; 463: 259–267
   PubMedGoogle Scholar
• Bohme I, Morl K, Bamming D, Meyer C, Beck-Sickinger A G. Tracking of human Y receptors in living cells–a fluorescence approach. Peptides 2007; 28: 226–234
   Google Scholar
• Parker S L, Balasubramaniam A. Neuropeptide YY2 receptor in health and disease. Br J Pharmacol 2008, doi:10.1038/sj.bjp.0707445
   Google Scholar
• Abbott C R, Small C J, Kennedy A R, Neary N M, Sajedi A, Ghatei M A, Bloom S R. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res 2005; 1043: 139–144
   PubMed Web of Science ®Google Scholar
• Pace A J, Gama L, Breitwieser G E. Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys → Ser mutations at Cys101 and Cys236. J Biol Chem 1999; 274: 11629–11634
   Google Scholar
• Rose P M, Fernandes P, Lynch J S, Frazier S T, Fisher S M, Kodukula K, Kienzle B, Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 1995; 270: 22661–22664
   PubMed Web of Science ®Google Scholar
• Rieu P, Sugimori T, Griffith D L, Arnaout M A. Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor. J Biol Chem 1996; 271: 15858–15861
   Google Scholar
• Guo W, Shi L, Javitch J A. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 2003; 278: 4385–4388
   PubMedGoogle Scholar
• Ma A W, Redka D S, Pisterzi L F, Angers S, Wells J W. Recovery of oligomers and cooperativity when monomers of the M2 muscarinic cholinergic receptor are reconstituted into phospholipid vesicles. Biochemistry 2007; 46: 7907–7927
   Google Scholar
• Abel P W, Han C, Noe B D, McDonald J K. Neuropeptide Y: vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage. Brain Res 1988; 463: 250–258
   Google Scholar
• Ekstrand A J, Cao R, Bjorndahl M, Nystrom S, Jonsson-Rylander A C, Hassani H, Hallberg B, Nordlander M, Cao Y. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 2003; 100: 6033–6038
   PubMed Web of Science ®Google Scholar
• Lee E W, Grant D S, Movafagh S, Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 2003; 24: 99–106
   PubMed Web of Science ®Google Scholar